11 D (Zidovudine 300 mg)
Pill imprint 11 D has been identified as Zidovudine 300 mg.
Zidovudine is used in the treatment of reduction of perinatal transmission of hiv; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 11 D
- 300 mg
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Aurobindo Pharma
- National Drug Code (NDC):
- Inactive Ingredients:
- hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
sodium starch glycolate type A potato
hypromellose 2910 (6 mPa.s)
|NDC Code||Manufacturer / Repackager|
|68084-0462||Amerisource Health Services|
|21695-0369||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about zidovudine
- Zidovudine capsules
- Zidovudine syrup
- Zidovudine injection
- Zidovudine (Advanced Reading)
- Zidovudine Intravenous (Advanced Reading)
- Other brands: Retrovir
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.